FDA Inspection 1197250 — Versiti Blood Health, Inc.
The FDA completed an inspection of Versiti Blood Health, Inc. on Feb 1, 2023 in Naperville, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 1, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Naperville, IL (United States)